Mannose receptor
Kocieba, M.
Postepy Higieny i Medycyny Doswiadczalnej 55(6): 759-773
2001
ISSN/ISBN: 0032-5449
PMID: 11875774
Accession: 045219887
PDF emailed within 1 workday: $29.90
Related References
Tam, T.; Langley, J. 2004: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Update: statement on influenza vaccination for the 2003-04 season Canada Communicable Disease Report 30: 1-5De Serres, G. 2000: An Advisory Committee Statement (ASC). National Advisory Committee on Immunization (NACI). Statement on adult/adolescent formulation of combined acellular pertussis, tetanus, and diphtheria vaccine Canada Communicable Disease Report 26: 1-8
2000: Statement on alternate adolescent schedule for hepatitis B vaccine (ACS-5). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) Canada Communicable Disease Report 26: 19-20
Serwer, A. 2003: HealthSouth's go-to guy Fortune 147(8): 38
2000: Supplementary statement on hepatitis A vaccine (ACS-4). An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) Canada Communicable Disease Report 26: 12-18
Tan, B.; Ismail, S. 2010: Updated Recommendations for the Use of Varicella and MMR Vaccines In HIV-Infected Individuals: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-7): 1-19
Tan, B.; Ismail, S. 2010: Varicella Vaccination Two-Dose Recommendations: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-8): 1-26
Desai, S.; McGeer, A.; Quach-Thanh, C.; Elliott, D. 2010: Update on the Use of Conjugate Pneumococcal Vaccines in Childhood: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-12): 1-21
Dawar, D.M.; Harris, M.T.; McNeil, D.S. 2012: Update on Human Papillomavirus (HPV) Vaccines: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 38(Acs-1): 1-62
2001: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Supplementary statement on influenza vaccination: continued use of Fluviral influenza vaccine in the 2000-2001 season Canada Communicable Disease Report 27: 1-3
Ford-Jones, E.L.; Calvin, S. 2010: Literature Review on Rotavirus: Disease and Vaccine Characteristics: An Advisory Committee Statement (ACS) National Advisory Committee on Immunization (NACI) † Canada Communicable Disease Report 36(Acs-14): 1-31
1998: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 1998-1999 season Canada Communicable Disease Report 24: 1-12
Pandey, S.; Srivastava, R.; Pandey, S.; Mukerjee, D.; Khattri, S.; Shanker, K. 2000: Effect of vitamin "A" on free radical cascade in pregnancy induced hypertension Bollettino Chimico Farmaceutico 139(2): 98-102
2003: An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2003-2004 season Canada Communicable Disease Report 29: 1-20
Orr, P. 2004: An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI). Statement on influenza vaccination for the 2004-2005 season Canada Communicable Disease Report 30: 1-32